Other languages AstraZeneca Pharma India Limited NSE India S.E.

Equities

ASTRAZEN

INE203A01020

Delayed NSE India S.E. Other stock markets 12:43:51 22/05/2024 BST			5-day change	1st Jan Change
5,753 ^INR	-0.51%		+4.77%	+4.10%

04-08	AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	CI
03-25	AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	04-08
AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	03-25
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	03-11
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	03-11
Astrazeneca Pharma India Limited Announces Board Changes	02-20
AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-08
AstraZeneca Pharma India Limited Announces Board Changes	02-08
AstraZeneca Pharma India Limited Announces Directorate Appointments	02-07
AstraZeneca Gets Indian Drug Regulator's Nod to Import Andexanet Alfa Powder for Solution for Infusion	01-22
Astrazeneca Pharma to Launch Breast Cancer Treatment Drug in India in January 2024	12-21
India's Nifty set for muted open after steep drop	12-21
Astrazeneca Pharma India Limited Appoints Hooi-Bien Chuah as Additional Director (Non-Executive)	11-09
AstraZeneca Pharma India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09
Astrazeneca Pharma India Limited Receives Permission to Import Pharmaceutical Formulations Of New Drug For Sale Or For Distribution In Form CT-20 From Central Drugs Standard Control Organisation For Palivizumab	30/09/23
Astrazeneca Pharma India Limited Announces Retirement of Rajesh Marwaha as Whole-Time Director	29/09/23
AstraZeneca Pharma India Limited Appoints Praveen Akkinepally as the Business Unit Head Oncology with Effect from November 1, 2023	15/09/23
AstraZeneca Pharma India Limited Approves Dividend for the Financial Year 2022-2023	17/08/23
AstraZeneca Pharma India Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23
AstraZeneca Pharma India Limited Announces Launch of Selumetinib 10 Mg and 25 Mg Capsule	09/08/23
AstraZeneca Pharma India Limited Announces Executive Changes	31/07/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages AstraZeneca Pharma India Limited NSE India S.E.

Equities

ASTRAZEN

INE203A01020

Other languages

Filters